CME TOPICAL SYMPOSIUM: Spinal muscular atrophy Chairperson
Ulrike Schara, Essen, Germany
Enrico Bertini, Roma, Italy Diagnosis of spinal muscular atrophy
W.Ludo Van Der Pol, Utrecht, The Netherlands Clinical aspects of spinal muscular atrophy
Ulrike Schara, Essen, Germany Therapy and management… Continue Reading

The third Women in Neurology Session: is the landscape really changing with respect to the gender gap? The “Challenges in for Women in Neurology” lunch session took place for the third time at EAN 2017 and featured three successful practitioners… Continue Reading

ILAE-CEA/EAN: Recent and upcoming new drugs and devices for the treatment of epilepsy CHAIRPERSONS: Meir Bialer, JERUSALEM, ISRAEL Paul Boon, GHENT, BELGIUM 25 years new anti-epileptic drugs – did they make a difference?
Eugen Trinka, SALZBURG, AUSTRIA New anti-epileptic drugs… Continue Reading

Amsterdam, 26 June 2017 – The Congress of the European Academy of Neurology (EAN) in Amsterdam received a royal visit today: H.M. Queen Máxima of the Netherlands attended the major scientific event at RAI Amsterdam, in which over 6,000 people… Continue Reading

Plenary Symposium 2: Presidential Symposium Main Auditorium, Sunday, June 25, 2017, 10:00-12:00 Chairperson Günther Deuschl, Kiel, Germany
Selma C Tromp, Nieuwegein, The Netherlands Moritz Romberg Lecture – Epilepsy: Where do we stand? Where are we headed?
Christian E. Elger, Bonn,… Continue Reading

The 3rd Congress of the EAN had its official opening on Saturday evening, June 24. Prof. Bernard Uitdehaag, chair of the local organizing committee, welcomed the 2,000 attendees to the ceremony. He illustrated the overarching theme of this year congress,… Continue Reading

During the Assembly of Delegates at the Amsterdam Congress, Professor Deuschl acknowledged Professor Pavel Kalvach’s longstanding tribute to the EAN, and also the former EFNS, as organizer of the EAN Spring School in Staré Splavy for the past 18 years.… Continue Reading

Syposium 4: Neuroscience of sleep Forum, Saturday, June 24, 2017, 10:30-12:30 Chairperson: Pierre Maquet, Liege, Belgium
Claudio Bassetti, Bern, Switzerland Effects of sleep/circadian disruption on cognition
Pierre Maquet, Liege, Belgium Sleep deprivation and diabetes/obesity
J A Hans Romijn, Amsterdam, The… Continue Reading

Syposium 3: DNA repeat syndromes in neuromuscular disorders   Elicium 1, Saturday, June 24, 2017, 10:30-12:30 Chairperson: Benedikt Schoser, Munich, Germany
Vincenzo Silani, Milano, Italy Amyotrophic lateral sclerosis (ALS) Vincenzo Silani, Milano, Italy Myotonic dystrophies
Benedikt Schoser, Munich, Germany  Facioscapulohumeral muscular… Continue Reading

Symposium 2: Overarching theme: Outcome measures in dementia studies Elicium 2, Saturday, June 24, 2017, 10:30-12:30 Chairperson: Philip Scheltens, Amstelveen, The Netherlands
Nick C. Fox, London, United Kingdom
Didier Leys, Lille, France Measuring instrumental activities of daily living (IADL) in… Continue Reading

Symposium 1: MDS-ES/EAN: The natural history of movement disorders Main Auditorium, Saturday, June 24, 2017, 10:30-12:30 Chairperson: Werner Poewe, Innsbruck, Austria
Evzen Ruzicka, Prague, Czech Republic Has deep brain stimulation (DBS) changed the natural history of Parkinson’s disease?
Werner Poewe,… Continue Reading

The Brain Prize is now open to researchers around the world   The Brain Prize was launched in 2011 and was awarded for the 7th time this year to Peter Dayan, Wolfram Schultz and Ray Dolan for their work on… Continue Reading

This year, The Brain Prize – the world’s most valuable prize for brain research – was awarded to Peter Dayan, Ray Dolan and Wolfram Schultz for their analysis of how the brain recognises and processes reward. The prize was presented… Continue Reading

The Value of Treatment Report was presented in Brussels on June 22nd 2017 at a medical conference organised by the European Brain Council (EBC). The European Union spends just over three euro a year per patient on research into brain disorders – while levels of access to treatment in many Member States are becoming worse, not better.